|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Minnesota Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MinnesotaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Nuvaira, Inc.
| Nuvaira, Inc. 3750 Annapolis Lane North, Suite 105 Plymouth, MN 55447 | |
| | Phone: | (763) 450-2800 | Year Established: | 2008 | Main Contact: | Shane Gleason, CCO | | Other Contacts: | Mahtab Fatemi, VP, Regulatory Affairs and Quality Jim Pavliska, VP, Clinical Affairs Kari Kubesh, CFO Steve Mertens, Senior VP, Operations Martin Mayse, M.D., Founder & CTO Dennis Wahr, M.D., President & CEO
| | Company Description | Nuvaira, formerly Innovative Pulmonary Solutions & Holaira, is a privately held lung denervation company that is developing the Nuvaira™ Lung Denervation System to address chronic obstructive pulmonary disease (COPD) by treating the overactive airway nerves during Targeted Lung Denervation* (TLD), a minimally invasive procedure that targets the parasympathetic innervation of the lungs[1]. This one-time bronchoscopic procedure provides an ablative therapy that opens obstructed airways to improve breathing. Nuvaira received CE Mark approval for its Nuvaira Lung Denervation System for use during TLD in January 2016. | |
|
|
|
|
|